ID   ATLA1_RAT               Reviewed;         558 AA.
AC   Q6PST4;
DT   22-SEP-2009, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 127.
DE   RecName: Full=Atlastin-1;
DE            EC=3.6.5.-;
DE   AltName: Full=Spastic paraplegia 3A homolog;
GN   Name=Atl1; Synonyms=Spg3a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=14506257; DOI=10.1074/jbc.m306702200;
RA   Zhu P.-P., Patterson A., Lavoie B., Stadler J., Shoeb M., Patel R.,
RA   Blackstone C.;
RT   "Cellular localization, oligomerization, and membrane association of the
RT   hereditary spastic paraplegia 3A (SPG3A) protein atlastin.";
RL   J. Biol. Chem. 278:49063-49071(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF ARG-217; ARG-239 AND
RP   HIS-258, AND DEVELOPMENTAL STAGE.
RX   PubMed=16537571; DOI=10.1093/hmg/ddl054;
RA   Zhu P.-P., Soderblom C., Tao-Cheng J.-H., Stadler J., Blackstone C.;
RT   "SPG3A protein atlastin-1 is enriched in growth cones and promotes axon
RT   elongation during neuronal development.";
RL   Hum. Mol. Genet. 15:1343-1353(2006).
RN   [4]
RP   INTERACTION WITH REEP5; RTN3 AND RTN4.
RX   PubMed=19665976; DOI=10.1016/j.cell.2009.05.025;
RA   Hu J., Shibata Y., Zhu P.-P., Voss C., Rismanchi N., Prinz W.A.,
RA   Rapoport T.A., Blackstone C.;
RT   "A class of dynamin-like GTPases involved in the generation of the tubular
RT   ER network.";
RL   Cell 138:549-561(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-22 AND SER-23, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [6]
RP   INTERACTION WITH ARL6IP1.
RX   PubMed=24262037; DOI=10.1042/bj20131186;
RA   Yamamoto Y., Yoshida A., Miyazaki N., Iwasaki K., Sakisaka T.;
RT   "Arl6IP1 has the ability to shape the mammalian ER membrane in a reticulon-
RT   like fashion.";
RL   Biochem. J. 458:69-79(2014).
CC   -!- FUNCTION: GTPase tethering membranes through formation of trans-
CC       homooligomers and mediating homotypic fusion of endoplasmic reticulum
CC       membranes. Functions in endoplasmic reticulum tubular network
CC       biogenesis. May also regulate Golgi biogenesis. May regulate axonal
CC       development. {ECO:0000250|UniProtKB:Q8WXF7,
CC       ECO:0000269|PubMed:16537571}.
CC   -!- SUBUNIT: Monomer as apoprotein and in the GDP-bound form. Homodimer in
CC       the GTP-bound form. Homooligomer. Interacts (via N-terminal region)
CC       with MAP4K4 (via CNH regulatory domain). Interacts with SPAST;
CC       interaction is direct (By similarity). Interacts with REEP5, RTN3 and
CC       RTN4 (via the transmembrane region) (PubMed:19665976). Interacts with
CC       REEP1 (By similarity). Interacts with CPT1C (By similarity). Interacts
CC       with ARL6IP1 (PubMed:24262037). Interacts with ZFYVE27 (By similarity).
CC       {ECO:0000250|UniProtKB:Q8BH66, ECO:0000250|UniProtKB:Q8WXF7,
CC       ECO:0000269|PubMed:19665976, ECO:0000269|PubMed:24262037}.
CC   -!- INTERACTION:
CC       Q6PST4; Q9JK11-1: Rtn4; NbExp=6; IntAct=EBI-2410213, EBI-919989;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:14506257}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:14506257}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:14506257}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:14506257}. Cell projection, axon
CC       {ECO:0000269|PubMed:16537571}. Note=Localizes to endoplasmic reticulum
CC       tubular network. {ECO:0000250|UniProtKB:Q8BH66}.
CC   -!- TISSUE SPECIFICITY: Detected in brain where it is abundant in lamina V
CC       of the cerebral cortex. Also expressed within the hippocampus, mainly
CC       in pyramidal neurons in CA1 and CA3. Weakly expressed in the striatum
CC       and more robustly in amygdala and several thalamic nuclei. Also
CC       detected in several mesopontine nuclei (at protein level).
CC       {ECO:0000269|PubMed:14506257}.
CC   -!- DEVELOPMENTAL STAGE: Expression increases gradually from 18 dpc through
CC       adulthood. {ECO:0000269|PubMed:16537571}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. GB1/RHD3 GTPase family. GB1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01052}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY581896; AAS89975.1; -; mRNA.
DR   EMBL; BC092645; AAH92645.1; -; mRNA.
DR   RefSeq; NP_001009831.1; NM_001009831.2.
DR   AlphaFoldDB; Q6PST4; -.
DR   SMR; Q6PST4; -.
DR   BioGRID; 263689; 2.
DR   IntAct; Q6PST4; 2.
DR   MINT; Q6PST4; -.
DR   STRING; 10116.ENSRNOP00000041993; -.
DR   iPTMnet; Q6PST4; -.
DR   PhosphoSitePlus; Q6PST4; -.
DR   SwissPalm; Q6PST4; -.
DR   jPOST; Q6PST4; -.
DR   PaxDb; 10116-ENSRNOP00000041993; -.
DR   Ensembl; ENSRNOT00000046085.6; ENSRNOP00000041993.4; ENSRNOG00000005063.8.
DR   Ensembl; ENSRNOT00055015133; ENSRNOP00055012094; ENSRNOG00055008958.
DR   Ensembl; ENSRNOT00060010341; ENSRNOP00060007691; ENSRNOG00060006290.
DR   Ensembl; ENSRNOT00065010620; ENSRNOP00065007840; ENSRNOG00065006820.
DR   GeneID; 362750; -.
DR   KEGG; rno:362750; -.
DR   UCSC; RGD:1359232; rat.
DR   AGR; RGD:1359232; -.
DR   CTD; 51062; -.
DR   RGD; 1359232; Atl1.
DR   eggNOG; KOG2037; Eukaryota.
DR   GeneTree; ENSGT00940000158704; -.
DR   HOGENOM; CLU_021447_2_0_1; -.
DR   InParanoid; Q6PST4; -.
DR   OMA; GFIHNIW; -.
DR   OrthoDB; 102682at2759; -.
DR   PhylomeDB; Q6PST4; -.
DR   TreeFam; TF105251; -.
DR   PRO; PR:Q6PST4; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000005063; Expressed in frontal cortex and 18 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0071782; C:endoplasmic reticulum tubular network; ISS:UniProtKB.
DR   GO; GO:0098826; C:endoplasmic reticulum tubular network membrane; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0000137; C:Golgi cis cisterna; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IMP:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; IMP:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; ISS:UniProtKB.
DR   GO; GO:1990809; P:endoplasmic reticulum tubular network membrane organization; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; ISS:UniProtKB.
DR   CDD; cd01851; GBP; 1.
DR   Gene3D; 1.20.58.420; AHSP; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   InterPro; IPR030386; G_GB1_RHD3_dom.
DR   InterPro; IPR036543; Guanylate-bd_C_sf.
DR   InterPro; IPR015894; Guanylate-bd_N.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10751:SF15; ATLASTIN-1; 1.
DR   PANTHER; PTHR10751; GUANYLATE BINDING PROTEIN; 1.
DR   Pfam; PF02263; GBP; 1.
DR   SUPFAM; SSF48340; Interferon-induced guanylate-binding protein 1 (GBP1), C-terminal domain; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS51715; G_GB1_RHD3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell projection; Coiled coil; Endoplasmic reticulum;
KW   Golgi apparatus; GTP-binding; Hydrolase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..558
FT                   /note="Atlastin-1"
FT                   /id="PRO_0000384814"
FT   TOPO_DOM        1..449
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        450..470
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        471
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        472..492
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        493..558
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   DOMAIN          64..309
FT                   /note="GB1/RHD3-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01052"
FT   REGION          1..447
FT                   /note="Redistribution to soluble cell fraction"
FT                   /evidence="ECO:0000250"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          448..558
FT                   /note="Sufficient for membrane association"
FT                   /evidence="ECO:0000250"
FT   COILED          412..439
FT                   /evidence="ECO:0000255"
FT   BINDING         74..81
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         118..120
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         217..218
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   BINDING         276..279
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         23
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         395
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6DD88"
FT   MUTAGEN         217
FT                   /note="R->Q: Loss of GTPase activity. No effect on
FT                   oligomerization."
FT                   /evidence="ECO:0000269|PubMed:16537571"
FT   MUTAGEN         239
FT                   /note="R->C: Loss of GTPase activity. No effect on
FT                   oligomerization."
FT                   /evidence="ECO:0000269|PubMed:16537571"
FT   MUTAGEN         258
FT                   /note="H->R: Loss of GTPase activity. No effect on
FT                   oligomerization."
FT                   /evidence="ECO:0000269|PubMed:16537571"
SQ   SEQUENCE   558 AA;  63375 MW;  4FFDE569007E171F CRC64;
     MAKSRRDRNS WGGFSEKSSD WSSEEEEPVR KAGPVQVLIV KDDHSFELDE AALNRILLSE
     AVRDKEVVAV SVAGAFRKGK SFLMDFMLRY MYNQESVDWV GDYNEPLTGF SWRGGSERET
     TGIQIWSEVF LINKLDGKKV AVLLMDTQGT FDSQSTLRDS ATVFALSTMI SSIQVYNLSQ
     NVQEDDLQHL QLFTEYGRLA MEETFLKPFQ SLIFLVRDWS FPYEFSYGAD GGAKFLEKRL
     KVSGNQHEEL QNVRKHIHSC FTNISCFLLP HPGLKVATNP NFDGKLKEID DEFIKNLKIL
     IPWLLSPESL DIKEINGNKI TCRGLLEYFK AYIKIYQGEE LPHPKSMLQA TAEANNLAAV
     ATAKDTYNKK MEEICGGDKP FLAPNDLQTK HLQLKEDSVK LFRGVKKMGG EEFSRRYLQQ
     LESEIDELYI QYIKHNDSKN IFHAARTPAT LFVVIFITYV IAGVTGFIGL DIIASLCNMI
     MGLTLITLCT WAYIRYSGEY RELGAVIDQV AAALWDQGST NEALYKLYSA AATHRHLYQQ
     AFPAPKSEPT EQPEKKKI
//
